The six-gate roadmap, Strategy Lock through Phase 2 Enablement, shows that the sequencing discipline built for one IND is what determines whether a company’s development engine can repeat for a second and third program.
White Paper
From IND to Phase 2: The 24 Months That Determine Whether Your Development Platform Scales
Related Resources
All Resources
case-study
Syner-G Partners with Leading Supplier in Life Sciences to Build Out New cGMP Compliant Facilities
Read More
case-study
Mobilizing Pharmaceutical Technology Transfers to a Contract Development and Manufacturing Organization (CDMO)
Read More
post
CFD Applications in Design of Manufacturing Processes and Facilities
Read More
post
How Regulatory Strategy Drives Innovation in Biopharma
Read More
Let's move from science to success.
Let’s Talk